18 November 2017
News and Views
Links and Services
November's issue of Gastroenterology investigates the impact of a cannabinoid agonist on colonic motility in patients with nonconstipated irritable bowel syndrome.
Cannabinoid receptors are located on cholinergic neurons. Genetic variants that affect endocannab
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors